Clariant reported a 3% decrease in sales to CHF 906 million in Q3 2025, with a 230 basis point increase in EBITDA margin before exceptional items to 17.9%. For the first nine months of 2025, sales decreased by 1% to CHF 2.887 billion, with an 18.0% EBITDA margin before exceptional items. The company’s Investor Day savings program is on track with CHF 31 million saved year-to-date. Sales outlook for 2025 confirmed at the lower end of 1-3% growth range.

Clariant’s CEO, Conrad Keijzer, highlighted the company’s growth in profitability in Q3 2025, driven by performance improvement programs and effective cost management. Care Chemicals sales decreased by 3%, Catalysts by 8%, and Adsorbents & Additives increased by 1% in local currencies. EBITDA margin before exceptional items improved across all business units.

In terms of sustainability, Clariant reduced its Scope 1 & 2 total greenhouse gas emissions by 12% in the last twelve months. The company achieved a DART rate of 0.11 in the first nine months of 2025, reflecting a strong commitment to safety and training. The outlook for 2025 includes an expected local currency sales growth at the lower end of 1-3% range, with a focus on continued profitability improvement and cost savings initiatives.

For the Business Unit Care Chemicals, sales decreased by 3% in Q3 2025, with an EBITDA margin before exceptional items of 18.9%. For Catalysts, sales decreased by 8% in Q3 2025, with an EBITDA margin before exceptional items of 19.3%. Adsorbents & Additives saw a 1% increase in sales in Q3 2025, with an EBITDA margin before exceptional items of 17.2%. The company’s restructuring programs are expected to deliver significant savings by 2027.

Read more at GlobeNewswire: Clariant increases Q3 2025 EBITDA margin before exceptional